Clinical Trial Update: Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors [Phase 1]

View source ↗

Summary

Phase 1 dose-finding study evaluating safety, tolerability, and pharmacokinetics of SNB-101 (SN-38) in patients with colorectal, breast, pancreatic, ovarian, sm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Gastric Cancer
• Head and Neck Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Small Cell Lung Cancer

Drugs mentioned

• SNB-101 (SN-38) (SN-38)

Snippet

Sponsor: SN BioScience | Conditions: Colorectal Cancer, Breast Cancer | Phase 1 | Status: COMPLETED